↓ Skip to main content

Estrogen Signaling and the DNA Damage Response in Hormone Dependent Breast Cancers

Overview of attention for article published in Frontiers in oncology, May 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
135 Dimensions

Readers on

mendeley
177 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Estrogen Signaling and the DNA Damage Response in Hormone Dependent Breast Cancers
Published in
Frontiers in oncology, May 2014
DOI 10.3389/fonc.2014.00106
Pubmed ID
Authors

C. Elizabeth Caldon

Abstract

Estrogen is necessary for the normal growth and development of breast tissue, but high levels of estrogen are a major risk factor for breast cancer. One mechanism by which estrogen could contribute to breast cancer is via the induction of DNA damage. This perspective discusses the mechanisms by which estrogen alters the DNA damage response (DDR) and DNA repair through the regulation of key effector proteins including ATM, ATR, CHK1, BRCA1, and p53 and the feedback on estrogen receptor signaling from these proteins. We put forward the hypothesis that estrogen receptor signaling converges to suppress effective DNA repair and apoptosis in favor of proliferation. This is important in hormone-dependent breast cancer as it will affect processing of estrogen-induced DNA damage, as well as other genotoxic insults. DDR and DNA repair proteins are frequently mutated or altered in estrogen responsive breast cancer, which will further change the processing of DNA damage. Finally, the action of estrogen signaling on DNA damage is also relevant to the therapeutic setting as the suppression of a DDR by estrogen has the potential to alter the response of cancers to anti-hormone treatment or chemotherapy that induces DNA damage.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 177 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 1%
Turkey 1 <1%
Unknown 174 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 30 17%
Student > Master 23 13%
Student > Bachelor 23 13%
Student > Ph. D. Student 20 11%
Professor > Associate Professor 10 6%
Other 31 18%
Unknown 40 23%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 44 25%
Agricultural and Biological Sciences 42 24%
Medicine and Dentistry 16 9%
Pharmacology, Toxicology and Pharmaceutical Science 11 6%
Engineering 3 2%
Other 13 7%
Unknown 48 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 October 2015.
All research outputs
#19,942,887
of 25,371,288 outputs
Outputs from Frontiers in oncology
#9,315
of 22,414 outputs
Outputs of similar age
#168,914
of 241,807 outputs
Outputs of similar age from Frontiers in oncology
#47
of 96 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,414 research outputs from this source. They receive a mean Attention Score of 3.0. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 241,807 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 96 others from the same source and published within six weeks on either side of this one. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.